Winnie joined the Health Economics Research Centre in October 2015. Before HERC, Winnie was working as a medical statistician for the China Kadoorie Biobank group within the Clinical Trial Service Unit investigating the causal effect of alcohol on various CVD risks.
Winnie is currently working with the REVEAL trial data for evaluation of the cost-effectiveness of Anacetrapib on CVD risk reduction in high risk populations. Winnie is also working on the RADIcAL trial to investigate the cost-effectiveness of LiverMultiScan in diagnosis and monitoring of non-alcoholic fatty liver diseases compared with usual care in three separate European countries.
Winnie holds an M.Phil in Epidemiology from University of Cambridge and an Honours B.Sc in Cell biology and biochemistry from University of Toronto. She also worked as a biochemistry analyst at Sanofi Pasteur in Toronto prior to her M.Phil degree.
Jones DA. et al, (2020), Clin Transl Radiat Oncol, 20, 19 - 26
Clark DW. et al, (2019), Nat Commun, 10
A Systematic Review of Health Economic Evaluations of Proton Beam Therapy for Adult Cancer: Appraising Methodology and Quality
GRAY A. et al, (2019), Clinical and Translational Radiation Oncology
Millwood IY. et al, (2019), Lancet, 393, 1831 - 1842